AT306240B - Verfahren zur Herstellung von neuen 7β-Acylamido-3-alkoxymethylceph-3-em-4-carbonsäuren und von Derivaten derselben - Google Patents

Verfahren zur Herstellung von neuen 7β-Acylamido-3-alkoxymethylceph-3-em-4-carbonsäuren und von Derivaten derselben

Info

Publication number
AT306240B
AT306240B AT811471A AT811471A AT306240B AT 306240 B AT306240 B AT 306240B AT 811471 A AT811471 A AT 811471A AT 811471 A AT811471 A AT 811471A AT 306240 B AT306240 B AT 306240B
Authority
AT
Austria
Prior art keywords
alkoxymethylceph
acylamido
derivatives
preparation
new
Prior art date
Application number
AT811471A
Other languages
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Application granted granted Critical
Publication of AT306240B publication Critical patent/AT306240B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT811471A 1967-08-21 1968-08-20 Verfahren zur Herstellung von neuen 7β-Acylamido-3-alkoxymethylceph-3-em-4-carbonsäuren und von Derivaten derselben AT306240B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38493/67A GB1241656A (en) 1967-08-21 1967-08-21 Improvements in or relating to cephalosporin compounds

Publications (1)

Publication Number Publication Date
AT306240B true AT306240B (de) 1973-03-26

Family

ID=10403828

Family Applications (2)

Application Number Title Priority Date Filing Date
AT811471A AT306240B (de) 1967-08-21 1968-08-20 Verfahren zur Herstellung von neuen 7β-Acylamido-3-alkoxymethylceph-3-em-4-carbonsäuren und von Derivaten derselben
AT811668A AT301018B (de) 1967-08-21 1968-08-20 Verfahren zur Herstellung von neuen 7β-Acylamido-3-alkoxymethylceph-3-em-4-carbonsäuren und von Derivaten derselben

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT811668A AT301018B (de) 1967-08-21 1968-08-20 Verfahren zur Herstellung von neuen 7β-Acylamido-3-alkoxymethylceph-3-em-4-carbonsäuren und von Derivaten derselben

Country Status (14)

Country Link
US (2) US3665003A (de)
JP (1) JPS5010873B1 (de)
AT (2) AT306240B (de)
BE (1) BE719710A (de)
CA (1) CA946381A (de)
CH (2) CH553817A (de)
DE (2) DE1795717A1 (de)
ES (1) ES357409A1 (de)
FR (2) FR1588246A (de)
GB (1) GB1241656A (de)
IE (1) IE32291B1 (de)
IL (1) IL30580A (de)
NL (1) NL159668B (de)
SE (1) SE386182B (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321364A2 (de) * 1987-12-12 1989-06-21 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Oral verabreichbare Cephalosporinderivate, ihre Herstellung und ihre Anwendungen
EP0649849A1 (de) * 1993-10-22 1995-04-26 Biochemie Gesellschaft M.B.H. Verfahren zur Herstellung von Cephalosporinen
WO2017153824A1 (en) 2016-03-07 2017-09-14 Dhanuka Laboratories Ltd. A process for alkylating the hydroxymethyl group at position -3 of cephalosporins

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS502518B1 (de) * 1970-12-24 1975-01-27
CH591500A5 (de) * 1972-06-29 1977-09-30 Ciba Geigy Ag
US3917587A (en) * 1972-11-28 1975-11-04 Lilly Co Eli Cephalosporin ethers
US3917588A (en) * 1972-11-28 1975-11-04 Lilly Co Eli {60 -Aminoacyl cephalosporin ethers
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
US4008231A (en) * 1975-09-15 1977-02-15 Eli Lilly And Company Preparation of 3-methoxymethylcephalosporins
FI771866A (de) * 1976-06-28 1977-12-29 Fujisawa Pharmaceutical Co
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
JPS5896091A (ja) * 1981-12-01 1983-06-07 Sankyo Co Ltd 3−アルコキシメチルセフアロスポリン類の製造法
AT384222B (de) * 1985-06-03 1987-10-12 Biochemie Gmbh Verfahren zur herstellung von 7-amino-3alkoxymethyl-3-cephem-4-carbonsaeuren
JPS6260212U (de) * 1985-06-28 1987-04-14
DE3789412T2 (de) * 1986-10-02 1994-06-30 Asahi Chemical Ind Verfahren zur Herstellung von 3-Alkoxymethylcephalosporinen.
JP2612493B2 (ja) * 1988-05-24 1997-05-21 旭化成工業株式会社 3―置換メチル―3―セフェム―4―カルボン酸類の製造方法
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
GB201818410D0 (en) * 2018-11-12 2018-12-26 Imperial Innovations Ltd Compounds

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321364A2 (de) * 1987-12-12 1989-06-21 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Oral verabreichbare Cephalosporinderivate, ihre Herstellung und ihre Anwendungen
EP0321364A3 (de) * 1987-12-12 1989-12-06 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Oral verabreichbare Cephalosporinderivate, ihre Herstellung und ihre Anwendungen
EP0649849A1 (de) * 1993-10-22 1995-04-26 Biochemie Gesellschaft M.B.H. Verfahren zur Herstellung von Cephalosporinen
EP0908461A1 (de) * 1993-10-22 1999-04-14 BIOCHEMIE Gesellschaft m.b.H. Verfahren zur Herstellung von Cephalosporinen
WO2017153824A1 (en) 2016-03-07 2017-09-14 Dhanuka Laboratories Ltd. A process for alkylating the hydroxymethyl group at position -3 of cephalosporins

Also Published As

Publication number Publication date
DE1795717A1 (de) 1974-02-28
JPS5010873B1 (de) 1975-04-24
ES357409A1 (es) 1970-03-01
DE1795188B2 (de) 1979-03-29
GB1241656A (en) 1971-08-04
FR1588246A (de) 1970-04-10
FR8172M (de) 1970-08-31
CH553817A (de) 1974-09-13
US3665003A (en) 1972-05-23
BE719710A (de) 1969-02-20
IL30580A (en) 1975-05-22
DE1795188C3 (de) 1979-11-22
IE32291B1 (en) 1973-06-13
CH571528A5 (de) 1976-01-15
AT301018B (de) 1972-08-25
SE386182B (sv) 1976-08-02
DE1795188A1 (de) 1972-03-16
US3790567A (en) 1974-02-05
NL159668B (nl) 1979-03-15
CA946381A (en) 1974-04-30
NL6811830A (de) 1969-02-25
IE32291L (en) 1969-02-21

Similar Documents

Publication Publication Date Title
AT292203B (de) Verfahren zur Herstellung von neuen 2-Aminoadenosinderivaten
CH515222A (de) Verfahren zur Herstellung von substituierten Thiopropionsäuren und Derivaten davon
AT284816B (de) Verfahren zur Herstellung von neuen Amino-monohalogenphenyläthanolaminen und von deren Salzen
AT306240B (de) Verfahren zur Herstellung von neuen 7β-Acylamido-3-alkoxymethylceph-3-em-4-carbonsäuren und von Derivaten derselben
AT277221B (de) Verfahren zur Herstellung von neuen 5-Nitro-2-furyl-2-isoxazolin-derivaten
CH487833A (de) Verfahren zur Herstellung von neuen Benzophenon-Derivaten
AT277985B (de) Verfahren zur Herstellung von neuen Nitro-furan-, -thiophen- oder -pyrrol-derivaten
AT301525B (de) Verfahren zur Herstellung von neuen β-Amino-β-hydroxyphenylalkancarbonsäuren und ihren Salzen
AT277248B (de) Verfahren zur Herstellung von neuen Isochinolinderivaten und Salzen hievon
AT280271B (de) Verfahren zur Herstellung von neuen Cumarinyl-v-triazoloxydderivaten
AT299172B (de) Verfahren zur Herstellung von neuen Naphthylisopropyl-Derivaten
AT273150B (de) Verfahren zur Herstellung von neuen 3-Dimethylsulfamoyl-phenthiazinderivaten und ihren Salzen
AT291297B (de) Verfahren zur Herstellung von neuen Aminoarylsilanolaten und Aminoarylsiloxanolen
AT281315B (de) Verfahren zur Herstellung von neuen 22-Amino-dinorcholanderivaten
AT277275B (de) Verfahren zur Herstellung von neuen Arylsulfonylharnstoffen und neuen Arylsulfonylthioharnstoffen
CH475270A (de) Verfahren zur Herstellung von neuen 5-Nitro-furyl-derivaten
AT277254B (de) Verfahren zur Herstellung von neuen Benzazepinopyridoindolderivaten
CH497411A (de) Verfahren zur Herstellung von neuen Homogonan-Derivaten
AT255412B (de) Verfahren zur Herstellung von neuen 3-Nitro-2-oxo-tetrahydroimidazolderivaten
AT266141B (de) Verfahren zur Herstellung von neuen Haxahydropyrimidinderivaten
CH509972A (de) Verfahren zur Herstellung von neuen Diisoeugenol-Derivaten
CH451141A (de) Verfahren zur Herstellung von neuen 1-Hydroxy-piperidinderivaten
AT271472B (de) Verfahren zur Herstellung von neuen 5-Nitrothiazol-Derivaten
AT279624B (de) Verfahren zur Herstellung von neuen Derivaten des α-Piperazino-phenylacetonitrils
AT270862B (de) Verfahren zur Herstellung von neuen 6-Acylaminopenicillansäuren

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee